Multiple drugsHepatitis B reactivation: 35 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1661卷 / 1期

关键词：

D O I：

10.1007/s40278-017-33520-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：232 / 232

相关论文

共 50 条

[31] Multiple drugsHepatitis B reactivation followed by rebound effect and off-label use: case report
Reactions Weekly, 2024, 2021 (1) : 333 - 333
[32] Multiple drugsHepatitis B reactivation, elevated liver enzymes and immune reconstitution inflammatory syndrome: case report
Reactions Weekly, 2017, 1674 (1) : 200 - 200
[33] Multiple drugsHepatitis and various other toxicities: 67 case reports
Reactions Weekly, 2019, 1736 (1) : 141 - 141
[34] Multiple drugsHepatitis fulminant and autoimmune hepatitis: 4 case reports
Reactions Weekly, 2024, 2027 (1) : 302 - 302
[35] Multiple drugsHepatitis B virus reactivation and drug induced liver injury: case report
Reactions Weekly, 2025, 2056 (1) : 338 - 338
[36] Multiple drugsBepatitis B virus reactivation: 2 case reports
Reactions Weekly, 2017, 1633 (1) : 518 - 518
[37] Multiple drugsHepatitis C virus reactivation and chronic hepatitis C exacerbation: case report
Reactions Weekly, 2022, 1917 (1) : 391 - 391
[38] Multiple drugsHepatitis: case report
Reactions Weekly, 2014, 1524 (1) : 142 - 142
[39] Multiple drugsHepatitis, arthralgia, inflammatory arthritis and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1908 (1) : 368 - 368
[40] Multiple drugsAcute flare of hepatitis B and hepatitis B reactivation : 4 case reports
Reactions Weekly, 2021, 1881 (1) : 171 - 171

← 1 2 3 4 5 →